StockData
NVONYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NONOF

NOVO NORDISK A S

Financials through fiscal 2025, year ended Dec 31, 2025
$38.42−0.41 (-1.06%)

Close on Oct 19, 2026

Earnings

Quarterly results announced on Form 8-K, Item 2.02

No earnings releases found

Novo Nordisk A S has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.

Press releases

Announcements Novo Nordisk A S filed with the SEC

  • FORM 6-K

    Event dated Oct 19, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Oct 12, 2023, from SEC EDGAR

  • FORM 6-K

    Event dated Oct 5, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Oct 2, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Sep 28, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Sep 21, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Sep 17, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Sep 14, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Sep 7, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Aug 31, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Aug 24, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Aug 17, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Aug 10, 2026, from SEC EDGAR

  • FORM 6-K

    Event dated Aug 6, 2026, from SEC EDGAR

  • Current report on Form 6-K

    Event dated Aug 4, 2026, from SEC EDGAR